The societal costs of research misconduct: Some method considerations from the DEFORM Project

被引:0
作者
Combe C.G. [1 ]
Faucheux S. [1 ]
Kuszla C. [2 ]
机构
[1] IFG Executive Education, INSEEC U, 43 Quai de Grenelle, Paris
[2] Université Paris Nanterre, 200 Avenue de la République, Nanterre
来源
Faucheux, Sylvie (sfaucheux@inseec.com) | 1600年 / Inderscience Publishers卷 / 23期
基金
欧盟地平线“2020”;
关键词
Deform; Dieselgate; Integrity; KQA; Occupational fraud; Research misconduct; Social costs;
D O I
10.1504/IJSD.2020.115210
中图分类号
学科分类号
摘要
While research misconduct (RM) and non-responsible innovation (NRI) engage distinct considerations of integrity and responsibility, we can link them with a broad vision of values for science in society. We present a novel econometric approach, developed in the European DEFORM Project, for estimation of the incidence and direct social costs of research misconduct by analysing RM as occupational fraud. This is applied to publicly funded research in Europe, to obtain empirical estimates of the order of magnitude of financial losses to research investors due to projects tainted by RM. Turning to the societal context, notably the incitation to fraud afforded by commercial and institutional performance pressures, we discuss the example of direct and indirect social costs of RM in the 'Dieselgate' scandal. We thus situate social costs of RM as one facet of quality assurance and governance of research activity and of the uses of science in society. © 2020 Inderscience Enterprises Ltd.. All rights reserved.
引用
收藏
页码:175 / 204
页数:29
相关论文
共 69 条
  • [21] Frame B., O'Connor M., Integrating valuation and deliberation: the purposes of sustainability assessment, Environmental Science and Policy, 14, 1, pp. 1-10, (2010)
  • [22] Friedrichs D.O., Trusted Criminals: White Collar Crime in Contemporary Society, (2010)
  • [23] Funtowicz S., Ravetz J., Uncertainty and Quality in Science for Policy, (1990)
  • [24] Galsworthy M.J., Hristovski D., Lusa L., Ernst K., Irwin R., Charlesworth K., Wismar M., McKee M., Academic output of 9 years of EU investment into health research, The Lancet, 380, pp. 971-972, (2014)
  • [25] Gammon E., Franzini L., Research misconduct oversight: defining case costs, Journal of Health Care Finance, 40, 2, pp. 75-99, (2013)
  • [26] Gee J., Button M., The Financial Cost of Fraud, (2015)
  • [27] George S.L., Research misconduct and data fraud in clinical trials: prevalence and causal factors, International Journal of Clinical Oncology, 21, 1, pp. 15-21, (2016)
  • [28] Haug C.J., Peer-review fraud - hacking the scientific publication process, New England Journal of Medicine, 373, 25, pp. 2393-2395, (2015)
  • [29] Hesselmann F., Wienefoet V., Reinhart M., Measuring scientific misconduct - lessons from criminology, Publications, 2, pp. 61-70, (2014)
  • [30] Holtfreter K., Is occupational fraud typical white-collar crime? A comparison of individual and organisational characteristics, Journal of Criminal Justice, 33, pp. 353-365, (2005)